Research ArticleArticle
The Association of HLA-class I Genes and the Extent of Atherosclerotic Plaques in Patients with Psoriatic Disease
Lihi Eder, Fatima Abji, Cheryl F. Rosen, Vinod Chandran, Richard J. Cook and Dafna D. Gladman
The Journal of Rheumatology September 2016, jrheum.151469; DOI: https://doi.org/10.3899/jrheum.151469
Lihi Eder
From the Women’s College Research Institute, Women’s College Hospital; the Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, and the Division of Dermatology, Toronto Western Hospital, Toronto, Ontario; and the Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. Supported by a grant from AbbVie, Canada. Dr. Eder was supported by the Krembil Foundation and a Canadian Institutes of Health Research (CIHR) fellowship award. The Psoriatic Arthritis Program is funded in part by The Arthritis Society, CIHR, and the Krembil Foundation. L. Eder, MD, PhD, Assistant Professor, Clinician Scientist, Women’s College Hospital and Division of Rheumatology, Department of Medicine, University of Toronto; F. Abji, MSc, Laboratory Manager, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital; C.F. Rosen, MD, Professor, Head of Division of Dermatology, Toronto Western Hospital and University Health Network, Department of Medicine, University of Toronto; V. Chandran, MD, DM, PhD, Assistant Professor, Co-director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Affiliate Scientist, Krembil Research Institute, and Division of Rheumatology, Department of Medicine, Department of Laboratory Medicine and Pathobiology, University of Toronto; R.J. Cook, PhD, Professor of Biostatistics, Department of Statistics and Actuarial Science, University of Waterloo; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital. Address correspondence to Dr. D.D. Gladman, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: dafna.gladman@utoronto.ca. Accepted for publication June 20, 2016.
Fatima Abji
From the Women’s College Research Institute, Women’s College Hospital; the Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, and the Division of Dermatology, Toronto Western Hospital, Toronto, Ontario; and the Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. Supported by a grant from AbbVie, Canada. Dr. Eder was supported by the Krembil Foundation and a Canadian Institutes of Health Research (CIHR) fellowship award. The Psoriatic Arthritis Program is funded in part by The Arthritis Society, CIHR, and the Krembil Foundation. L. Eder, MD, PhD, Assistant Professor, Clinician Scientist, Women’s College Hospital and Division of Rheumatology, Department of Medicine, University of Toronto; F. Abji, MSc, Laboratory Manager, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital; C.F. Rosen, MD, Professor, Head of Division of Dermatology, Toronto Western Hospital and University Health Network, Department of Medicine, University of Toronto; V. Chandran, MD, DM, PhD, Assistant Professor, Co-director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Affiliate Scientist, Krembil Research Institute, and Division of Rheumatology, Department of Medicine, Department of Laboratory Medicine and Pathobiology, University of Toronto; R.J. Cook, PhD, Professor of Biostatistics, Department of Statistics and Actuarial Science, University of Waterloo; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital. Address correspondence to Dr. D.D. Gladman, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: dafna.gladman@utoronto.ca. Accepted for publication June 20, 2016.
Cheryl F. Rosen
From the Women’s College Research Institute, Women’s College Hospital; the Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, and the Division of Dermatology, Toronto Western Hospital, Toronto, Ontario; and the Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. Supported by a grant from AbbVie, Canada. Dr. Eder was supported by the Krembil Foundation and a Canadian Institutes of Health Research (CIHR) fellowship award. The Psoriatic Arthritis Program is funded in part by The Arthritis Society, CIHR, and the Krembil Foundation. L. Eder, MD, PhD, Assistant Professor, Clinician Scientist, Women’s College Hospital and Division of Rheumatology, Department of Medicine, University of Toronto; F. Abji, MSc, Laboratory Manager, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital; C.F. Rosen, MD, Professor, Head of Division of Dermatology, Toronto Western Hospital and University Health Network, Department of Medicine, University of Toronto; V. Chandran, MD, DM, PhD, Assistant Professor, Co-director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Affiliate Scientist, Krembil Research Institute, and Division of Rheumatology, Department of Medicine, Department of Laboratory Medicine and Pathobiology, University of Toronto; R.J. Cook, PhD, Professor of Biostatistics, Department of Statistics and Actuarial Science, University of Waterloo; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital. Address correspondence to Dr. D.D. Gladman, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: dafna.gladman@utoronto.ca. Accepted for publication June 20, 2016.
Vinod Chandran
From the Women’s College Research Institute, Women’s College Hospital; the Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, and the Division of Dermatology, Toronto Western Hospital, Toronto, Ontario; and the Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. Supported by a grant from AbbVie, Canada. Dr. Eder was supported by the Krembil Foundation and a Canadian Institutes of Health Research (CIHR) fellowship award. The Psoriatic Arthritis Program is funded in part by The Arthritis Society, CIHR, and the Krembil Foundation. L. Eder, MD, PhD, Assistant Professor, Clinician Scientist, Women’s College Hospital and Division of Rheumatology, Department of Medicine, University of Toronto; F. Abji, MSc, Laboratory Manager, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital; C.F. Rosen, MD, Professor, Head of Division of Dermatology, Toronto Western Hospital and University Health Network, Department of Medicine, University of Toronto; V. Chandran, MD, DM, PhD, Assistant Professor, Co-director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Affiliate Scientist, Krembil Research Institute, and Division of Rheumatology, Department of Medicine, Department of Laboratory Medicine and Pathobiology, University of Toronto; R.J. Cook, PhD, Professor of Biostatistics, Department of Statistics and Actuarial Science, University of Waterloo; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital. Address correspondence to Dr. D.D. Gladman, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: dafna.gladman@utoronto.ca. Accepted for publication June 20, 2016.
Richard J. Cook
From the Women’s College Research Institute, Women’s College Hospital; the Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, and the Division of Dermatology, Toronto Western Hospital, Toronto, Ontario; and the Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. Supported by a grant from AbbVie, Canada. Dr. Eder was supported by the Krembil Foundation and a Canadian Institutes of Health Research (CIHR) fellowship award. The Psoriatic Arthritis Program is funded in part by The Arthritis Society, CIHR, and the Krembil Foundation. L. Eder, MD, PhD, Assistant Professor, Clinician Scientist, Women’s College Hospital and Division of Rheumatology, Department of Medicine, University of Toronto; F. Abji, MSc, Laboratory Manager, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital; C.F. Rosen, MD, Professor, Head of Division of Dermatology, Toronto Western Hospital and University Health Network, Department of Medicine, University of Toronto; V. Chandran, MD, DM, PhD, Assistant Professor, Co-director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Affiliate Scientist, Krembil Research Institute, and Division of Rheumatology, Department of Medicine, Department of Laboratory Medicine and Pathobiology, University of Toronto; R.J. Cook, PhD, Professor of Biostatistics, Department of Statistics and Actuarial Science, University of Waterloo; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital. Address correspondence to Dr. D.D. Gladman, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: dafna.gladman@utoronto.ca. Accepted for publication June 20, 2016.
Dafna D. Gladman
From the Women’s College Research Institute, Women’s College Hospital; the Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, and the Division of Dermatology, Toronto Western Hospital, Toronto, Ontario; and the Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. Supported by a grant from AbbVie, Canada. Dr. Eder was supported by the Krembil Foundation and a Canadian Institutes of Health Research (CIHR) fellowship award. The Psoriatic Arthritis Program is funded in part by The Arthritis Society, CIHR, and the Krembil Foundation. L. Eder, MD, PhD, Assistant Professor, Clinician Scientist, Women’s College Hospital and Division of Rheumatology, Department of Medicine, University of Toronto; F. Abji, MSc, Laboratory Manager, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital; C.F. Rosen, MD, Professor, Head of Division of Dermatology, Toronto Western Hospital and University Health Network, Department of Medicine, University of Toronto; V. Chandran, MD, DM, PhD, Assistant Professor, Co-director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, and Affiliate Scientist, Krembil Research Institute, and Division of Rheumatology, Department of Medicine, Department of Laboratory Medicine and Pathobiology, University of Toronto; R.J. Cook, PhD, Professor of Biostatistics, Department of Statistics and Actuarial Science, University of Waterloo; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital. Address correspondence to Dr. D.D. Gladman, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St. 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: dafna.gladman@utoronto.ca. Accepted for publication June 20, 2016.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
The Association of HLA-class I Genes and the Extent of Atherosclerotic Plaques in Patients with Psoriatic Disease
Lihi Eder, Fatima Abji, Cheryl F. Rosen, Vinod Chandran, Richard J. Cook, Dafna D. Gladman
The Journal of Rheumatology Sep 2016, jrheum.151469; DOI: 10.3899/jrheum.151469